Who and when should we screen for prostate cancer? Interviews with key opinion leaders Journal Article

   


Authors: Carlsson, S.; Leapman, M.; Carroll, P.; Schröder, F.; Albertsen, P. C.; Ilic, D.; Barry, M.; Frosch, D. L.; Vickers, A.
Article Title: Who and when should we screen for prostate cancer? Interviews with key opinion leaders
Abstract: Prostate cancer screening using prostate-specific antigen (PSA) is highly controversial. In this Q & A, Guest Editors for BMC Medicine's 'Spotlight on Prostate Cancer' article collection, Sigrid Carlsson and Andrew Vickers, invite some of the world's key opinion leaders to discuss who, and when, to screen for prostate cancer. In response to the points of view from the invited experts, the Guest Editors summarize the experts' views and give their own personal opinions on PSA screening. © 2015 Carlsson et al.
Journal Title: BMC Medicine
Volume: 13
ISSN: 1741-7015
Publisher: Biomed Central Ltd  
Date Published: 2015-11-27
Start Page: 288
Language: English
DOI: 10.1186/s12916-015-0526-x
PROVIDER: scopus
PMCID: PMC4662021
PUBMED: 26612204
DOI/URL:

http://www.scopus.com/inward/record.url?eid=2-s2.0-84960454211&partnerID=40&md5=8004f0ff2e2ac63c7a8580a0e08317dd
Notes: Article -- Export Date: 4 April 2016 -- Source: Scopus
Altmetric
What is Altmetric?
Citation Impact
What is Dimensions Citation Badge?
BMJ Impact Analytics
MSK Authors
  1. Andrew J Vickers
    880 Vickers
  2. Sigrid Viktoria Carlsson
    220 Carlsson
Related MSK Work